Terms: = Lung cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2
85057 results:
1. A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada.
Tan VS; Tjong MC; Chan WC; Yan M; Delibasic V; Darling G; Davis LE; Doherty M; Hallet J; Kidane B; Mahar A; Mittmann N; Parmar A; Tan H; Wright FC; Coburn NG; Louie AV
Support Care Cancer; 2024 May; 32(6):381. PubMed ID: 38787434
[TBL] [Abstract] [Full Text] [Related]
2. Sentinel Lymph Node Mapping in lung cancer: A Pilot Study for the Detection of Micrometastases in Stage I Non-Small Cell lung cancer.
Romano G; Zirafa CC; Calabrò F; Alì G; Manca G; De Liperi A; Proietti A; Manfredini B; Di Stefano I; Marciano A; Davini F; Volterrani D; Melfi F
Tomography; 2024 May; 10(5):761-772. PubMed ID: 38787018
[TBL] [Abstract] [Full Text] [Related]
3. Effects of sEH inhibition on the eicosanoid and cytokine storms in SARS-CoV-2-infected mice.
Edin ML; Gruzdev A; Graves JP; Lih FB; Morisseau C; Ward JM; Hammock BD; Bosio CM; Zeldin DC
FASEB J; 2024 May; 38(10):e23692. PubMed ID: 38786655
[TBL] [Abstract] [Full Text] [Related]
4. Real-World Evidence Study of Patients with
Anttalainen A; Pietarinen P; Tuominen S; Mattila R; Mutka A; Knuuttila A
Curr Oncol; 2024 May; 31(5):2700-2712. PubMed ID: 38785486
[TBL] [Abstract] [Full Text] [Related]
5. Real-World Analysis of Post-Progression Treatment Patterns and Outcomes for
Gibson AJW; Dean ML; Litt I; Box A; Cheung WY; Navani V
Curr Oncol; 2024 Apr; 31(5):2427-2440. PubMed ID: 38785463
[No Abstract] [Full Text] [Related]
6. Prevalence and prognosis of malignancy in THSD7A-associated membranous nephropathy: a systematic literature review and clinical case study.
Xu Q; Li J; Yang Y; Zhuo L; Gao H; Jiang S; Li W
Ren Fail; 2024 Dec; 46(1):2355353. PubMed ID: 38785304
[TBL] [Abstract] [Full Text] [Related]
7. [Transthoracic CT-guided core biopsy of high pulmonary neoplasms using coaxial transport system in a day hospital of oncology center].
Perepelevsky AN; Stanoevich US; Gorivodsky VE
Khirurgiia (Mosk); 2024; (5):28-35. PubMed ID: 38785236
[TBL] [Abstract] [Full Text] [Related]
8. Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review).
Taylor J; Dubois F; Bergot E; Levallet G
Int J Oncol; 2024 Jul; 65(1):. PubMed ID: 38785155
[TBL] [Abstract] [Full Text] [Related]
9. [3D tumor spheroids promote activation, expansion, and anti-tumor effects of tumor-infiltrating lymphocytes
Xu X; Zhang Y; Wang Z; Zhang Q; Li Y; Dai J; Gao Y; Xiong Z; Chen L
Sheng Wu Gong Cheng Xue Bao; 2024 May; 40(5):1523-1535. PubMed ID: 38783813
[TBL] [Abstract] [Full Text] [Related]
10. The effect of enhanced recovery after lung cancer surgery combined with fine surgical nursing on rehabilitation.
Dong J; Zhu X
J Pak Med Assoc; 2024 May; 74(5):874-879. PubMed ID: 38783433
[TBL] [Abstract] [Full Text] [Related]
11. Diagnostic and therapeutic challenges in a recurrent endometrial carcinoma in lung, 15 years after primary treatment.
Upadhyay AK; Kumar M; Prakash A; Kumar A
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38782427
[TBL] [Abstract] [Full Text] [Related]
12. cancer Treatment Before and After Physician-Pharmacy Integration.
Kanter GP; Ozluk P; Chi W; Fisch MJ; Debono D; Parikh RB; Jacobson M; Bekelman JE; DeVries A
JAMA Netw Open; 2024 May; 7(5):e2412998. PubMed ID: 38780938
[TBL] [Abstract] [Full Text] [Related]
13. The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort.
Li X; Wu D; Tang J; Wu Y
J Cancer Res Clin Oncol; 2024 May; 150(5):271. PubMed ID: 38780840
[TBL] [Abstract] [Full Text] [Related]
14. Risk factors for pulmonary complications after colorectal cancer surgery: a Japanese multicenter study.
Tominaga T; Nonaka T; Takamura Y; Oishi K; Hashimoto S; Shiraishi T; Noda K; Ono R; Ishii M; Hisanaga M; Takeshita H; Fukuoka H; Oyama S; Ishimaru K; Kunizaki M; Sawai T; Matsumoto K
Int J Colorectal Dis; 2024 May; 39(1):76. PubMed ID: 38780615
[TBL] [Abstract] [Full Text] [Related]
15. The association of preoperative hematologic parameters with short-term clinical outcomes in rectal cancer: A feature importance analysis.
Orafaie A; Shahabi F; Mehri A; Ansari M; Kasraeifar S; Ghiyasi M; Saberi-Karimian M; Abdollahi A; Tabatabaei SM
Cancer Med; 2024 May; 13(10):e7225. PubMed ID: 38778698
[TBL] [Abstract] [Full Text] [Related]
16. 3,3'-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration.
Luo W; Chang G; Lin D; Xie H; Sun H; Li Z; Mo S; Wang R; Wang Y; Zheng Z
PLoS One; 2024; 19(5):e0303186. PubMed ID: 38776295
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of Pm2.5 Influence on Human lung cancer Cells Using a Microfluidic Platform.
Nguyen UTN; Hsieh HY; Chin TY; Wu G; Lin YP; Lee CY; Hsu YC; Fan YJ
Int J Med Sci; 2024; 21(6):1117-1128. PubMed ID: 38774761
[TBL] [Abstract] [Full Text] [Related]
18.
McMahon NP; Solanki A; Wang LG; Montaño AR; Jones JA; Samkoe KS; Tichauer KM; Gibbs SL
Theranostics; 2024; 14(7):2816-2834. PubMed ID: 38773974
[No Abstract] [Full Text] [Related]
19. Integrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cell-related regulon predicting neoadjuvant immunotherapy response across cancers.
Liu H; Sima X; Xiao B; Gulizeba H; Zhao S; Zhou T; Huang Y
J Transl Med; 2024 May; 22(1):486. PubMed ID: 38773508
[TBL] [Abstract] [Full Text] [Related]
20. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer.
Ma H; Wu T; Zhang Q; Ding Q
BMC Pulm Med; 2024 May; 24(1):250. PubMed ID: 38773432
[TBL] [Abstract] [Full Text] [Related]
[Next]
